You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-HLA-A (HLA-A) Antibodies

Full name:
anti-Major Histocompatibility Complex, Class I, A Antibodies (HLA-A)
On www.antibodies-online.com are 172 Major Histocompatibility Complex, Class I, A (HLA-A) Antibodies from 20 different suppliers available. Additionally we are shipping HLA-A Proteins (44) and HLA-A Kits (4) and many more products for this protein. A total of 225 HLA-A products are currently listed.
Synonyms:
HLAA
list all antibodies Gene Name GeneID UniProt
HLA-A 3105 P30443 , P04439
HLA-A    
HLA-A    

Show all species

Show all synonyms

Most Popular Reactivities for anti-HLA-A (HLA-A) Antibodies

Select your species and application

anti-Human HLA-A Antibodies:

anti-Mouse (Murine) HLA-A Antibodies:

anti-Rat (Rattus) HLA-A Antibodies:

All available anti-HLA-A Antibodies

Go to our pre-filtered search.

Top referenced anti-HLA-A Antibodies

  1. Human Monoclonal HLA-A Primary Antibody for FACS, ICFC - ABIN2659031 : Nicodemus, Wang, Lucas, Varghese, Berek: Toll-like receptor-3 as a target to enhance bioactivity of cancer immunotherapy. in American journal of obstetrics and gynecology 2010 (PubMed)
    Show all 10 references for ABIN2659031

  2. Human Monoclonal HLA-A Primary Antibody for FACS - ABIN2657515 : Darrow, Slingluff, Seigler: The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. in Journal of immunology (Baltimore, Md. : 1950) 1989 (PubMed)
    Show all 9 references for ABIN2657515

  3. Human Monoclonal HLA-A Primary Antibody for FACS - ABIN2657919 : Ayyoub, Taub, Keohan, Hesdorffer, Metthez, Memeo, Mansukhani, Hibshoosh, Hesdorffer, Valmori: The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma. in Cancer immunity 2004 (PubMed)
    Show all 9 references for ABIN2657919

  4. Human Monoclonal HLA-A Primary Antibody for FACS, IF - ABIN2663732 : Barbatis, Woods, Morton, Fleming, McMichael, McGee: Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody. in Gut 1982 (PubMed)
    Show all 9 references for ABIN2663732

  5. Human Monoclonal HLA-A Primary Antibody for FACS, ICFC - ABIN2658757 : De Felice, Turco, Costanzo, Corbo, Ferrone, Venuta: Inhibition by anti-HLA class I mAb of IL-2 and IL-2 receptor synthesis in lymphocytes stimulated with PHA-P. in Cellular immunology 1990 (PubMed)
    Show all 9 references for ABIN2658757

  6. Human Monoclonal HLA-A Primary Antibody for FACS - ABIN2661910 : Fayen, Huang, Ferrone, Tykocinski: Negative signaling by anti-HLA class I antibodies is dependent upon two triggering events. in International immunology 1998 (PubMed)
    Show all 9 references for ABIN2661910

  7. Human Monoclonal HLA-A Primary Antibody for FACS, IP - ABIN2662341 : Geppert, Wacholtz, Patel, Lightfoot, Lipsky: Activation of human T cell clones and Jurkat cells by cross-linking class I MHC molecules. in Journal of immunology (Baltimore, Md. : 1950) 1989 (PubMed)
    Show all 9 references for ABIN2662341

  8. Mouse (Murine) Polyclonal HLA-A Primary Antibody for IHC, WB - ABIN3023100 : Parham, Lomen, Lawlor, Ways, Holmes, Coppin, Salter, Wan, Ennis: Nature of polymorphism in HLA-A, -B, and -C molecules. in Proceedings of the National Academy of Sciences of the United States of America 1988 (PubMed)
    Show all 2 references for ABIN3023100

  9. Human Monoclonal HLA-A Primary Antibody for FACS - ABIN4900774 : Loubaki, Chabot, Bazin: Involvement of the TNF-α/TGF-β/IDO axis in IVIg-induced immune tolerance. in Cytokine 2015 (PubMed)
    Show all 2 references for ABIN4900774

More Antibodies against HLA-A Interaction Partners

Human Major Histocompatibility Complex, Class I, A (HLA-A) interaction partners

  1. The host HLA class I (show MICA Antibodies) polymorphism might play an important role with the occurrence of Severe fever with thrombocytopenia syndrome (SFTS). A*30-B*13-DRB1 (show RBM45 Antibodies)*07 had negative correlation with the occurrence of SFTS; in contrast, haplotype A*02-B*15-DRB1 (show RBM45 Antibodies)*04 was positively correlated with SFTS.

  2. data show that sequence similarity does not translate to structural mimicry of the paired epitopes in complexes with HLA-A*02:01, resulting in induction of distinct alphabetaTCR repertoires.

  3. Results provide evidence that HLA-A*02:06/-B*39:01 haplotype is a potential genetic marker for tetanus antitoxin-induced exanthematous drug eruptions.

  4. This study suggests that HLA-A*66:01 might be a marker for cmarkers only in those of European ancestry cold medicine Stevens-Johnson Syndrome with ocular complications in Brazilian individuals of Pardo and European ancestry and that HLA-B*44:03 and HLA-C*12:03 might be .

  5. findings suggest that in Hodgkin's lymphoma patients, HLA-A*29 allele might be a presumptive predisposing factor.

  6. We found that the HLA-A*02-B*46 haplotype might be a prognostic marker in addition to the traditional TNM (show ODZ1 Antibodies) staging in patients with We found that the HLA-A*02-B*46 haplotype might be a prognostic marker in addition to the traditional TNM (show ODZ1 Antibodies) staging in patients with NPC (show NPC1 Antibodies).

  7. we report genomic full-length sequence of a novel HLA-A*11:01:01:02 allele identified in a Chinese individual. HLA-A*11:01:01:02 has three nucleotide differences from HLA-A*11:01:01:01

  8. This is the first study in which the optimal HLA-A*0201 GPC3 (show GPC3 Antibodies) epitopes were screened from a large number of candidates predicted by three software. The optimized HLA-A*0201 GPC3 (show GPC3 Antibodies) peptides will provide new epitope candidates for hepatocellular carcinoma (HCC (show FAM126A Antibodies)) immunotherapy.

  9. This study indicated that the frequency of the A*03 allele, the DRB1 (show RBM45 Antibodies)*03 allele, the DRB1 (show RBM45 Antibodies)*04 allele, the A*02/B*35/DRB1 (show RBM45 Antibodies)*13 haplotype, and A*02 homozygosity may play a predisposing role in patients with ALL in the Turkish population.

  10. HLA-A*33 allele was significantly increased as compared to control population and showed geographic variation in hepatitis C virus-infected individuals of India.

HLA-A Antigen Profile

Antigen Summary

HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-A alleles have been described.

Alternative names and synonyms associated with HLA-A

  • major histocompatibility complex, class I, A (HLA-A) antibody
  • HLAA antibody

Protein level used designations for HLA-A

HLA class I histocompatibility antigen, A-1 alpha chain , MHC class I antigen HLA-A heavy chain , antigen presenting molecule , leukocyte antigen class I-A

GENE ID SPECIES
3105 Homo sapiens
Selected quality suppliers for anti-HLA-A (HLA-A) Antibodies
Did you look for something else?